Cellectis (CLLS) EPS (Diluted) Growth (3y) (2018 - 2026)
Cellectis (CLLS) EPS (Diluted) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 99.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.85% |
| Dec 31, 2025 | 99.84% |
| Sep 30, 2025 | 26.19% |
| Jun 30, 2025 | 17.17% |
| Mar 31, 2025 | 99.86% |
| Dec 31, 2024 | 28.41% |
| Sep 30, 2024 | 34.58% |
| Jun 30, 2024 | 34.65% |
| Mar 31, 2024 | 30.01% |
| Dec 31, 2023 | 8.20% |
| Sep 30, 2023 | 23.83% |
| Jun 30, 2023 | 34.77% |
| Mar 31, 2023 | -47.93% |
| Dec 31, 2022 | 12.41% |
| Sep 30, 2022 | -18.38% |
| Jun 30, 2022 | 19.15% |
| Mar 31, 2022 | -25.01% |
| Dec 31, 2021 | -0.95% |
| Sep 30, 2021 | -15.73% |
| Jun 30, 2021 | -72.59% |